Cell-Guided Biomaterials era
Larry Hench’s development of bioactive glasses established the principle that interfacial surface chemistry can drive bone-like apatite nucleation and biointegration, informing cell-guided material strategies in the late 1990s. Robert Langer advanced biodegradable polymer scaffolds, notably PLLA-based architectures with controlled porosity and degradation, to provide a matrix that supports cell adhesion, migration, and differentiation. Joseph Vacanti highlighted clinical translation and autologous progenitor approaches, combining cell-seeded scaffolds with composites such as PLLA/HA to operationalize cell-guided regeneration. David A. Mooney contributed to surface and scaffold design that tunes osteogenic cues and links material degradation with host remodeling, reflecting the era’s emphasis on multiscale structure–function relationships.